Grupo Roche Holding AG

Acción

Mercado cerrado - Swiss Exchange Otros sitios de cotización 17:31:14 13/09/2024			Varia. Cinco días.	Varia. 1 de enero.
265,60 ^CHF	+0,99 %		-3,14 %	+8,63 %

13/09	La FDA aprueba el tratamiento de la esclerosis múltiple de Roche con el sistema de administración de Halozyme	MT
13/09	Halozyme Therapeutics, Inc. Anuncia la aprobación por la FDA de OCREVUS ZUNOVO subcutáneo de Roche con ENHANZE para personas con esclerosis múltiple recidivante y primaria progresiva	CI

Empresa	Director
Roche Pharmholding BV Roche Pharmholding BV Medical DistributorsDistribution Services Part of Roche Holding AG, Roche Pharmholding BV is a Dutch company that manufactures and distributes pharmaceutical and vitamin products. The company is based in Woerden, Netherlands.	-
Roche Intertrade Ltd.	-
Roche Financial Investments Ltd.	-
Roche Catalyst Investments Ltd.	-
Roche Finance Europe BV	-
Roche Diagnostics Belgium NV Roche Diagnostics Belgium NV BiotechnologyHealth Technology Part of Roche Holding AG, Roche Diagnostics Belgium NV is a Belgian company that develops innovative products and services for the prevention, diagnosis, monitoring, screening, and treatment of diseases. Roche Diagnostics Belgium is based in Diegem, Belgium, and was founded in 1958. The company offers next-generation sequencing products and in vitro diagnostics that are an integral part of decision-making along the entire continuum of a patient's health or disease. The CEO is Thomas Schinecker.	Thomas Schinecker